Internationales Symposium für Evidenzbasierte Cochrane Reviews in der Hämatologie:
10. Jahrestag der Cochrane Haematological Malignancies Group 

CHMG-Symposium:  Programm

Freitag, 08. Juli 2011,

09.00 – 16.00 Uhr

Uniklinik Köln, 50937 Köln

Referenten: 

Dr. Gerd Antes, German Cochrane Centre, Freiburg (DE)

Prof. Peter Borchmann, University Hospital of Cologne, Clinic I for Internal Medicine, Cologne (DE)

Prof. Ben Djulbegovic, Lee Moffitt Cancer Centre and Research Institute, University of South Florida, Tampa, Tampa (USA)

Prof. Andreas Engert, Clinic I for Internal Medicine, Cologne (DE)

Dr. Markus Follmann, German Cancer Society, Berlin (DE)

Céline Fournier, WA Centre for Cancer and Palliative Care, Curtin University, Perth (AU)

Prof. Michael Hallek, Clinic I for Internal Medicine, University Hospital of Cologne (DE)

Dr. Rainer Hess, Federal Joint Committee (G-BA), Berlin (DE)

Prof. Axel Heyll, Medical Review Board of Statutory Health Insurance Funds North-Rhine, Düsseldorf (DE)

Dr. Martin Hutchings, Department of Oncology, Copenhagen University Hospital (DK)

Prof. Tom Jefferson, Cochrane Acute Respiratory Infections Group, Rome (IT)

Prof. Ina Kopp, AWMF, Institute for the Management of Medical Knowledge, Marburg/Lahn (DE)

Prof. Dr. Thomas Krieg, Medical Faculty of the University of Cologne (DE)

Toby Lasserson, Msc, Cochrane Editorial Unit, London (GB)

Dr. Monika Lelgemann, Medical Service of the Central Federal Association of Health Insurance, Essen (DE)

Prof. Pia Raanani, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva (IL)

Dr. Sue Richards, Clinical Trials Services Unit, Oxford University (GB)

PD Dr. Stephan Schmitz, Practicing haematologists and oncologists in Germany (BNHO), Cologne (DE)

Dr. Nicole Skoetz, Clinic I for Internal Medicine, University Hospital of Cologne (DE)

Prof. Lena Specht, Department of Oncology, Copenhagen University Hospital (DK)

Dr. Christiane Steinmüller, Project Management Agency in the DLR (PT-DLR) on behalf of the Federal Ministry of Education and Research (BMBF), Bonn (DE)

Dr. Siegfried Throm, vfa, Research-based Pharmaceutical Companies, Berlin (DE)

Dr. Sven Trelle, Institute of Social and Preventive Medicine, University of Bern (CH)

Prof. Keith Wheatley, Cancer Research UK Clinical Trials Unit, University of Birmingham (GB)

Prof. Jürgen Windeler, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne (DE)

Für weitere Informationen wenden Sie sich bitte an Frau Schmidtke (Bettina.Schmidtke@uk-koeln.de) 

Prof. Dr. Andreas Engert, Co-ordinating Editor CHMG und das Team der Editorial Base